In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Central Pharmaceuticals Inc.

Division of UCB Group

Latest From Central Pharmaceuticals Inc.

Schwarz Pharma's Middle Way

When the branded generics that long sustained Schwarz Pharma began losing value, and former Big Pharma partners took on their own distribution, the firm realized it must change. The mid-sized European company determined to aggressively in-license products and also began looking for companies to acquire. To fuel its aspirations, Schwarz made an unusual move for a family-owned European company; it issued public stock as a way to get cash and acquisition currency.
BioPharmaceutical Strategy

Elan & Athena: Selling out, Trading up

Athena's frustration with Wall Street and with its Big Pharma partners clearly led to its willingness to listen to Elan's acquisition offer-other similarly placed biotechs are likely to abandon strategies focused on independence.
BioPharmaceutical Strategy

The New Deal Structures: The Recipe is Creativity

With capital markets depressed and internal R&D growing ever more expensive, biotech and Big Pharma need each other more than ever. But a new wave of skeptical drug partners are forcing humbled biotechs to write deals that minimize risk without driving down the deal's value.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • UCB Group
  • Senior Management
  • Daniel J Desmond, Pres., COO, CEO
  • Contact Info
  • Central Pharmaceuticals Inc.
    Phone: (812) 522-3915
    120 E. Third Street
    P.O. Box 328 Seymour, IN 47274-0328
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register